Home › Lung Cancer › NCT00471978

DNA Analysis of Blood and Tissue from Patients with Lung Cancer

Molecular and Genetic Analysis of Lung Cancer

Who can join

Ages 18 to 120 · All sexes · Healthy volunteers welcome

DISEASE CHARACTERISTICS:

* Patient:

  * Newly diagnosed primary lung cancer

    * Patient at Massachusetts General Hospital (MGH) or Boston Medical Center Cancer Center

PATIENT CHARACTERISTICS:

* Not specified

PRIOR CONCURRENT THERAPY:

* Not specified

EXCLUSIONS:

Vulnerable populations are excluded. Patients with metastasis from another site to lung or mesothelioma are excluded.

About the study

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future.

PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.

Sponsor: Massachusetts General Hospital · Started: 2005-09

Contact the study team

Official record on ClinicalTrials.gov — NCT00471978

Locations in the U.S.

Conditions

• Lung Cancer
• Non-Small Cell Lung Cancer
• Small Cell Lung Cancer

From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.